Clinical Trial Update: Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating azithromycin to prevent wheezing after severe RSV bronchiolitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Bronchiolitis
• Wheezing

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Respiratory Syncytial Virus, Bronchiolitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-06-07